Gallstone disease(GD) is a chronic recurrent hepatobiliary disease,the basis for which is the impaired metabolism of cholesterol,bilirubin and bile acids,which is characterized by the formation of gallstones in the h... Gallstone disease(GD) is a chronic recurrent hepatobiliary disease,the basis for which is the impaired metabolism of cholesterol,bilirubin and bile acids,which is characterized by the formation of gallstones in the hepatic bile duct,common bile duct,or gallbladder.GD is one of the most prevalent gastrointestinal diseases with a substantial burden to health care systems.GD can result in serious outcomes,such as acute gallstone pancreatitis and gallbladder cancer.The epidemiology,pathogenesis and treatment of GD are discussed in this review.The prevalence of GD varies widely by region.The prevalence of gallstone disease has increased in recent years.This is connected with a change in lifestyle:reduction of motor activity,reduction of the physical load and changes to diets.One of the important benefits of early screening for gallstone disease is that ultrasonography can detect asymptomatic cases,which results in early treatment and the prevention of serious outcomes.The pathogenesis of GD is suggested to be multifactorial and probably develops from complex interactions between many genetic and environmental factors.It suggests that corticosteroids and oral contraceptives,which contain hormones related to steroid hormones,may be regarded as a model system of cholelithiasis development in man.The achievement in the study of the physiology of bile formation and the pathogenesis of GD has allowed expanding indications for therapeutic treatment of GD.展开更多
BACKGROUND: Stone recurrence is a major problem in the medication of gallstones with gallbladder preservation. The aim of this study was to determine the long-term recurrence rate of gallstones and the clinical outcom...BACKGROUND: Stone recurrence is a major problem in the medication of gallstones with gallbladder preservation. The aim of this study was to determine the long-term recurrence rate of gallstones and the clinical outcome after successful percutaneous cholecystolithotomy (PCCL) treatment, and to investigate the possible risk factors for gallstone recurrence. METHODS: After successful PCCL for gallstones, 439 patients were followed up during a 10-year period. The long-term gallstone recurrence rate and clinical outcome were evaluated. Risk factors associated with stone recurrence were identified. RESULTS: Gallstone recurrence was detected in 182 of 439 PCCL patients, giving an overall recurrence rate of 41.46%. The cumulative gallstone recurrence rate for each of the 10 post-operative years was 9.57%, 18.91%, 27.33%, 34.14%, 37.59%, 39.86%, 41.90%, 42.73%, 42.85%, and 43.21%, respectively. Among these recurrent patients, 94 were asymptomatic, 80 suffered from nonspecific upper gastrointestinal symptoms and 8 suffered from abdominal pain or biliary colic. Thirty-eight of the 182 patients were retreated with cholecystectomy. The risk factors for stone recurrence included a family history of gallstones, preference for fatty food, accompanying liver disease, multiple stones and poor gallbladder function pre-PCCL. CONCLUSIONS: In this study, the overall recurrence rate of gallstone was 41.46% during a 10-year period. The highest frequency of gallstone recurrence was during the 5th to 6th postoperative years and then continued to slowly increase. Risk factors for stone recurrence varied. We suggest that the use of PCCL in patients with gallstones should be considered carefully because of stone recurrence.展开更多
目的:观察腹腔镜胆囊切除术治疗胆囊结石合并急性胆囊炎的疗效及对免疫功能和生活质量的影响。方法:本次研究为回顾性研究,分析2018年3月~2021年3月期间我院收治的98例胆囊结石合并急性胆囊炎患者的临床资料,根据手术方案的不同将患者分...目的:观察腹腔镜胆囊切除术治疗胆囊结石合并急性胆囊炎的疗效及对免疫功能和生活质量的影响。方法:本次研究为回顾性研究,分析2018年3月~2021年3月期间我院收治的98例胆囊结石合并急性胆囊炎患者的临床资料,根据手术方案的不同将患者分为A组(n=46,给予开腹手术)和B组(n=52,给予腹腔镜胆囊切除术),记录两组患者围术期相关指标、肝功能、免疫功能、生活质量和并发症发生率。结果:B组术中出血量少于A组,切口大小短于A组,手术时间长于A组,住院时间、首次排气时间短于A组(P<0.05)。两组术后3 d总胆红素(TBIL)、谷丙转氨酶(ALT)、谷草转氨酶(AST)均升高,但B组低于A组(P<0.05)。B组术后3 d CD3^(+)、CD4^(+)、NK细胞、CD4^(+)/CD8^(+)高于A组(P<0.05),B组术后3 d CD8^(+)低于A组(P<0.05)。B组术后3个月健康生活量表简表(SF-36)各维度评分高于A组(P<0.05)。B组术后并发症发生率虽低于A组,但组间对比差异无统计学意义(P>0.05)。结论:腹腔镜胆囊切除术治疗胆囊结石合并急性胆囊炎,虽然手术时间较开腹手术更长,但切口小、可促进患者术后恢复,对患者免疫功能、肝功能损害更轻,有利于提高患者生活质量。展开更多
目的探讨腹腔镜与术中胆道镜联合治疗胆囊结石并肝外胆管结石患者的临床疗效。方法选取82例胆囊结石合并肝外胆管结石患者作为本次研究的对象,经随机数字表法将其随机分为观察组与对照组,观察组行腹腔镜与胆道镜联合手术治疗,对照组行...目的探讨腹腔镜与术中胆道镜联合治疗胆囊结石并肝外胆管结石患者的临床疗效。方法选取82例胆囊结石合并肝外胆管结石患者作为本次研究的对象,经随机数字表法将其随机分为观察组与对照组,观察组行腹腔镜与胆道镜联合手术治疗,对照组行开腹手术治疗。比较两组的临床指标、并发症、结石清除及复发情况。结果观察组术中出血量、住院时间以及术后肛门排气时间均少于对照组(P<0.05),而手术时间比较两组差异无统计学意义(P>0.05);观察组术后并发症总发生率显著低于对照组(14.6 vs 36.6%,P<0.05);两组结石清除率均为100%,观察组术后1年复发率低于对照组比较差异无统计学意义(2.4%vs 7.3%,P>0.05)。结论腹腔镜联合胆道镜治疗胆囊结石合并肝外胆管结石具有创伤小、患者恢复快等优势,能够显著减少并发症的发生率,值得临床推广。展开更多
目的分析腹腔镜胆囊切除术(LC)对胆结石患者血清胆囊收缩素A型受体(CCK-A)、固醇调节元件结合蛋白2(SREBP-2)及胆红素(TCB)水平的影响。方法选取2017年6月至2019年4月我院收治的胆结石患者140例,依据非随机临床同期对照研究及患者自愿...目的分析腹腔镜胆囊切除术(LC)对胆结石患者血清胆囊收缩素A型受体(CCK-A)、固醇调节元件结合蛋白2(SREBP-2)及胆红素(TCB)水平的影响。方法选取2017年6月至2019年4月我院收治的胆结石患者140例,依据非随机临床同期对照研究及患者自愿原则分为观察组合和对照组各70例。对照组予以小切口胆囊切除术(MC),观察组予以LC术,比较两组手术一般情况、手术前后血清CCK-A、SREBP-2、TCB、疼痛(简化McGill疼痛问卷)、并发症发生率。结果观察组手术时间、术后住院时间、肠鸣音复常时间、下地活动时间均短于对照组,术中出血量较对照组低(P<0.05);观察组术后CCK-A水平高于对照组,SREBP-2、TCB低于对照组(P<0.05);观察组术后1、3、7 d McGill评分低于对照组(P<0.05),术后1个月内并发症发生率低于对照组(P<0.05)。结论与MC术相比,LC术治疗胆结石疗效更好,可有效促进患者术后恢复,提高CCK-A水平,下调SREBP-2、TCB及炎症因子水平,降低疼痛和并发症风险,值得临床推广实践。展开更多
文摘 Gallstone disease(GD) is a chronic recurrent hepatobiliary disease,the basis for which is the impaired metabolism of cholesterol,bilirubin and bile acids,which is characterized by the formation of gallstones in the hepatic bile duct,common bile duct,or gallbladder.GD is one of the most prevalent gastrointestinal diseases with a substantial burden to health care systems.GD can result in serious outcomes,such as acute gallstone pancreatitis and gallbladder cancer.The epidemiology,pathogenesis and treatment of GD are discussed in this review.The prevalence of GD varies widely by region.The prevalence of gallstone disease has increased in recent years.This is connected with a change in lifestyle:reduction of motor activity,reduction of the physical load and changes to diets.One of the important benefits of early screening for gallstone disease is that ultrasonography can detect asymptomatic cases,which results in early treatment and the prevention of serious outcomes.The pathogenesis of GD is suggested to be multifactorial and probably develops from complex interactions between many genetic and environmental factors.It suggests that corticosteroids and oral contraceptives,which contain hormones related to steroid hormones,may be regarded as a model system of cholelithiasis development in man.The achievement in the study of the physiology of bile formation and the pathogenesis of GD has allowed expanding indications for therapeutic treatment of GD.
文摘BACKGROUND: Stone recurrence is a major problem in the medication of gallstones with gallbladder preservation. The aim of this study was to determine the long-term recurrence rate of gallstones and the clinical outcome after successful percutaneous cholecystolithotomy (PCCL) treatment, and to investigate the possible risk factors for gallstone recurrence. METHODS: After successful PCCL for gallstones, 439 patients were followed up during a 10-year period. The long-term gallstone recurrence rate and clinical outcome were evaluated. Risk factors associated with stone recurrence were identified. RESULTS: Gallstone recurrence was detected in 182 of 439 PCCL patients, giving an overall recurrence rate of 41.46%. The cumulative gallstone recurrence rate for each of the 10 post-operative years was 9.57%, 18.91%, 27.33%, 34.14%, 37.59%, 39.86%, 41.90%, 42.73%, 42.85%, and 43.21%, respectively. Among these recurrent patients, 94 were asymptomatic, 80 suffered from nonspecific upper gastrointestinal symptoms and 8 suffered from abdominal pain or biliary colic. Thirty-eight of the 182 patients were retreated with cholecystectomy. The risk factors for stone recurrence included a family history of gallstones, preference for fatty food, accompanying liver disease, multiple stones and poor gallbladder function pre-PCCL. CONCLUSIONS: In this study, the overall recurrence rate of gallstone was 41.46% during a 10-year period. The highest frequency of gallstone recurrence was during the 5th to 6th postoperative years and then continued to slowly increase. Risk factors for stone recurrence varied. We suggest that the use of PCCL in patients with gallstones should be considered carefully because of stone recurrence.
文摘目的:观察腹腔镜胆囊切除术治疗胆囊结石合并急性胆囊炎的疗效及对免疫功能和生活质量的影响。方法:本次研究为回顾性研究,分析2018年3月~2021年3月期间我院收治的98例胆囊结石合并急性胆囊炎患者的临床资料,根据手术方案的不同将患者分为A组(n=46,给予开腹手术)和B组(n=52,给予腹腔镜胆囊切除术),记录两组患者围术期相关指标、肝功能、免疫功能、生活质量和并发症发生率。结果:B组术中出血量少于A组,切口大小短于A组,手术时间长于A组,住院时间、首次排气时间短于A组(P<0.05)。两组术后3 d总胆红素(TBIL)、谷丙转氨酶(ALT)、谷草转氨酶(AST)均升高,但B组低于A组(P<0.05)。B组术后3 d CD3^(+)、CD4^(+)、NK细胞、CD4^(+)/CD8^(+)高于A组(P<0.05),B组术后3 d CD8^(+)低于A组(P<0.05)。B组术后3个月健康生活量表简表(SF-36)各维度评分高于A组(P<0.05)。B组术后并发症发生率虽低于A组,但组间对比差异无统计学意义(P>0.05)。结论:腹腔镜胆囊切除术治疗胆囊结石合并急性胆囊炎,虽然手术时间较开腹手术更长,但切口小、可促进患者术后恢复,对患者免疫功能、肝功能损害更轻,有利于提高患者生活质量。
文摘目的探讨腹腔镜与术中胆道镜联合治疗胆囊结石并肝外胆管结石患者的临床疗效。方法选取82例胆囊结石合并肝外胆管结石患者作为本次研究的对象,经随机数字表法将其随机分为观察组与对照组,观察组行腹腔镜与胆道镜联合手术治疗,对照组行开腹手术治疗。比较两组的临床指标、并发症、结石清除及复发情况。结果观察组术中出血量、住院时间以及术后肛门排气时间均少于对照组(P<0.05),而手术时间比较两组差异无统计学意义(P>0.05);观察组术后并发症总发生率显著低于对照组(14.6 vs 36.6%,P<0.05);两组结石清除率均为100%,观察组术后1年复发率低于对照组比较差异无统计学意义(2.4%vs 7.3%,P>0.05)。结论腹腔镜联合胆道镜治疗胆囊结石合并肝外胆管结石具有创伤小、患者恢复快等优势,能够显著减少并发症的发生率,值得临床推广。
文摘目的分析腹腔镜胆囊切除术(LC)对胆结石患者血清胆囊收缩素A型受体(CCK-A)、固醇调节元件结合蛋白2(SREBP-2)及胆红素(TCB)水平的影响。方法选取2017年6月至2019年4月我院收治的胆结石患者140例,依据非随机临床同期对照研究及患者自愿原则分为观察组合和对照组各70例。对照组予以小切口胆囊切除术(MC),观察组予以LC术,比较两组手术一般情况、手术前后血清CCK-A、SREBP-2、TCB、疼痛(简化McGill疼痛问卷)、并发症发生率。结果观察组手术时间、术后住院时间、肠鸣音复常时间、下地活动时间均短于对照组,术中出血量较对照组低(P<0.05);观察组术后CCK-A水平高于对照组,SREBP-2、TCB低于对照组(P<0.05);观察组术后1、3、7 d McGill评分低于对照组(P<0.05),术后1个月内并发症发生率低于对照组(P<0.05)。结论与MC术相比,LC术治疗胆结石疗效更好,可有效促进患者术后恢复,提高CCK-A水平,下调SREBP-2、TCB及炎症因子水平,降低疼痛和并发症风险,值得临床推广实践。